Dow ends more than 500 points higher after Fed delivers rate hike
Stocks ended sharply higher Wednesday in a session marked by big swings after the Federal Reserve delivered a widely expected quarter-point rate hike and penciled...
WD-40 CEO Garry Ridge to retire, COO Steve Brass to become CEO
WD-40 Co. said late Wednesday that Chief Executive Garry Ridge will retire from his post on Aug. 31 as part of a "planned leadership transition."...
Williams-Sonoma Q4 profit beats expectations, retailer raises dividend by 10%
Shares of Williams-Sonoma Inc. rallied more than 10% in the extended session Wednesday after the retailer reported quarterly profit above expectations and raised its dividend....
Lennar stock rises more than 2% after Q1 profit tops views
Lennar Corp. shares rose more than 2% in the extended session Wednesday after the home builder reported first-quarter profit that topped Wall Street expectations and...
Nordstrom resumes dividend
Nordstrom Inc. said late Wednesday it is reinstating a quarterly dividend, with the company's board of directors approving a quarterly dividend of 19 cents a...
Moderna begins testing experimental HIV vaccine in an early-stage clinical trial
Shares of Moderna Inc. soared 19.2% in trading on Monday after the company announced that it began dosing participants in a Phase 1 clinical trial...
SVB Leerink: AstraZeneca’s Lynparza could bring in $9.7 billion in sales by 2028
The Food and Drug Administration's approval on Friday of AstraZeneca's Lynparza as a treatment for some people with early-stage breast cancer could bring in $1.5...
Bloomberg study flags lower refinancing approvals for African Americans by Wells Fargo
African American homeowners drew the lowest mortgage refinancing approval rate by lenders nationwide and also had the lowest number of applicants, according to a study...
Nektar’s stock falls 44% after experimental therapy fails to work in melanoma patients
Shares of Nektar Therapeutics Inc. tumbled 44.7% in premarket trading on Monday after the company said a combination of its experimental therapy bempegaldesleukin in combination...